Innate immune response of human alveolar macrophages during influenza a infection

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Wang, Jieru ^a,c   Nikrad, Mrinalini P ^a   Travanty, Emily A ^a   Zhou, Bin ^b   Phang, Tzulip ^c   Gao, Bifeng ^c   Alford, Taylor ^a   Ito, Yoko ^a   Nahreini, Piruz ^a   Hartshorn, Kevan ^d   Wentworth, David ^b   Dinarello, Charles A ^c   Mason, Robert J ^a,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD36 ANTIGEN; CXCL11 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; DECTIN 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 29; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE SCAVENGER RECEPTOR 1; MANNOSE RECEPTOR; MANNOSE RECEPTOR C TYPE 1; MESSENGER RNA; RANTES; SCAVENGER RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN; CHEMOKINE; CYTOKINE; LECTIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE GENE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS INACTIVATION; BIOSYNTHESIS; DNA MICROARRAY; GENETICS; IMMUNOLOGY; INFLUENZA; KINETICS; LUNG ALVEOLUS; MACROPHAGE; METABOLISM; METHODOLOGY; PHAGOCYTOSIS; VIROLOGY;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

CHEMOKINES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; KINETICS; LECTINS, C-TYPE; MACROPHAGES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHAGOCYTOSIS; PULMONARY ALVEOLI; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84863290608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029879     Document Type: Article

References (64)

1. Sibille Y, Reynolds HY, (1990) Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141: 471-501.
2. Lambrecht BN, (2006) Alveolar macrophage in the driver's seat. Immunity 24: 366-368.
3. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, et al. (2009) Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol 182: 1296-1304.
4. Stafford JL, Neumann NF, Belosevic M, (2002) Macrophage-mediated innate host defense against protozoan parasites. Crit Rev Microbiol 28: 187-248.
5. Krutzik SR, Modlin RL, (2004) The role of Toll-like receptors in combating mycobacteria. Semin Immunol 16: 35-41.
6. McGill J, Heusel JW, Legge KL, (2009) Innate immune control and regulation of influenza virus infections. J Leukoc Biol 86: 803-812.
7. Castleman WL, Powe JR, Crawford PC, Gibbs EP, Dubovi EJ, et al. (2010) Canine H3N8 Influenza Virus Infection in Dogs and Mice. Vet Pathol.
8. Chen Y, Deng W, Jia C, Dai X, Zhu H, et al. (2009) Pathological lesions and viral localization of influenza A (H5N1) virus in experimentally infected Chinese rhesus macaques: implications for pathogenesis and viral transmission. Arch Virol 154: 227-233.
9. Coleman JR, (2007) The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J 4: 9.
10. Guarner J, Falcon-Escobedo R, (2009) Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res 40: 655-661.
11. Kim HM, Lee YW, Lee KJ, Kim HS, Cho SW, et al. (2008) Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol 82: 4265-4274.
12. Lohr CV, Debess EE, Baker RJ, Hiett SL, Hoffman KA, et al. (2010) Pathology and Viral Antigen Distribution of Lethal Pneumonia in Domestic Cats Due to Pandemic (H1N1) 2009 Influenza A Virus. Vet Pathol.
13. Powe JR, Castleman WL, (2009) Canine influenza virus replicates in alveolar macrophages and induces TNF-alpha. Vet Pathol 46: 1187-1196.
14. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, et al. (2005) Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 79: 14933-14944.
15. Gill JR, Sheng ZM, Ely SF, Guinee DG, Beasley MB, et al. (2010) Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 134: 235-243.
16. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831-1837.
17. Lee SM, Gardy JL, Cheung CY, Cheung TK, Hui KP, et al. (2009) Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 4: e8072.
18. Zhou J, Law HK, Cheung CY, Ng IH, Peiris JS, et al. (2006) Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 194: 61-70.
19. Yu WC, Chan RW, Wang J, Travanty EA, Nicholls JM, et al. (2011) Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol 85: 6844-6855.
20. Hofmann P, Sprenger H, Kaufmann A, Bender A, Hasse C, et al. (1997) Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol 61: 408-414.
21. Sakabe S, Iwatsuki-Horimoto K, Takano R, Nidom CA, Le MQ, et al. (2011) Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J Gen Virol 92: 1428-1434.
22. van Riel D, Leijten LM, van der Eerden M, Hoogsteden HC, Boven LA, et al. (2011) Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction. PLoS Pathog 7: e1002099.
23. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, et al. (2009) Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol 83: 10309-10313.
24. Groom JR, Luster AD, (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89: 207-215.
25. Cassel SL, Rothman PB, (2009) Chapter 3: Role of SOCS in allergic and innate immune responses. Advances in immunology 103: 49-76.
26. Gordy LE, Bezbradica JS, Flyak AI, Spencer CT, Dunkle A, et al. (2011) IL-15 Regulates Homeostasis and Terminal Maturation of NKT Cells. J Immunol.
27. McAleer JP, Kolls JK, (2011) Mechanisms controlling Th17 cytokine expression and host defense. J Leukoc Biol 90: 263-270.
28. Jankowski M, Kopinski P, Goc A, (2010) Interleukin-27: biological properties and clinical application. Arch Immunol Ther Exp (Warsz) 58: 417-425.
29. Miura TA, Wang J, Holmes KV, Mason RJ, (2007) Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines. Virology 369: 288-298.
30. Dinarello CA, (2010) Anti-inflammatory Agents: Present and Future. Cell 140: 935-950.
31. Cilloniz C, Shinya K, Peng X, Korth MJ, Proll SC, et al. (2009) Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 5: e1000604.
32. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 106: 3455-3460.
33. Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, et al. (2008) Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol 82: 11308-11317.
34. Wang J, Nikrad MP, Phang T, Gao B, Alford T, et al. (2011) Innate immune response to influenza A virus in differentiated human alveolar type II cells. Am J Respir Cell Mol Biol 45: 582-591.
35. Takeuchi O, Akira S, (2007) Recognition of viruses by innate immunity. Immunol Rev 220: 214-224.
36. Thompson AJ, Locarnini SA, (2007) Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol 85: 435-445.
37. Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, et al. (2009) Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J Infect Dis 200: 1774-1780.
38. Fadel SA, Bromley SK, Medoff BD, Luster AD, (2008) CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality. Eur J Immunol 38: 3376-3387.
39. Thapa M, Carr DJ, (2009) CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration. J Virol 83: 9486-9501.
40. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, et al. (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6: 135.
41. Fife BT, Kennedy KJ, Paniagua MC, Lukacs NW, Kunkel SL, et al. (2001) CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166: 7617-7624.
42. Larrubia JR, Benito-Martinez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T, (2008) Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 14: 7149-7159.
43. Hamilton NH, Mahalingam S, Banyer JL, Ramshaw IA, Thomson SA, (2004) A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo. Scand J Immunol 59: 246-254.
44. Harvey SA, Romanowski EG, Yates KA, Gordon YJ, (2005) Adenovirus-directed ocular innate immunity: the role of conjunctival defensin-like chemokines (IP-10, I-TAC) and phagocytic human defensin-alpha. Invest Ophthalmol Vis Sci 46: 3657-3665.
45. Ji R, Lee CM, Gonzales LW, Yang Y, Aksoy MO, et al. (2008) Human type II pneumocyte chemotactic responses to CXCR3 activation are mediated by splice variant A. Am J Physiol Lung Cell Mol Physiol 294: L1187-1196.
46. Yates CC, Whaley D, A YC, Kulesekaran P, Hebda PA, et al. (2008) ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. Am J Pathol 173: 643-652.
47. Hooper JD, Clements JA, Quigley JP, Antalis TM, (2001) Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 276: 857-860.
48. Bottcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, et al. (2006) Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 80: 9896-9898.
49. Bottcher-Friebertshauser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, et al. (2010) Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol 84: 5605-5614.
50. Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M, (2005) Biological activity of interleukins-28 and-29: comparison with type I interferons. Cytokine 31: 109-118.
51. Bussfeld D, Kaufmann A, Meyer RG, Gemsa D, Sprenger H, (1998) Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell Immunol 186: 1-7.
52. Maines TR, Szretter KJ, Perrone L, Belser JA, Bright RA, et al. (2008) Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 225: 68-84.
53. Elsharkawy AM, Oakley F, Lin F, Packham G, Mann DA, et al. (2010) The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. Journal of hepatology 53: 519-527.
54. Sun K, Metzger DW, (2008) Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 14: 558-564.
55. Peiser L, Mukhopadhyay S, Gordon S, (2002) Scavenger receptors in innate immunity. Curr Opin Immunol 14: 123-128.
56. Arredouani M, Yang Z, Ning Y, Qin G, Soininen R, et al. (2004) The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med 200: 267-272.
57. Arredouani MS, Yang Z, Imrich A, Ning Y, Qin G, et al. (2006) The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am J Respir Cell Mol Biol 35: 474-478.
58. Zhou H, Imrich A, Kobzik L, (2008) Characterization of immortalized MARCO and SR-AI/II-deficient murine alveolar macrophage cell lines. Part Fibre Toxicol 5: 7.
59. Thomas CA, Li Y, Kodama T, Suzuki H, Silverstein SC, et al. (2000) Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med 191: 147-156.
60. Nugent KM, Pesanti EL, (1982) Staphylococcal clearance and pulmonary macrophage function during influenza infection. Infect Immun 38: 1256-1262.
61. Jakab GJ, (1982) Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia. Am Rev Respir Dis 126: 778-782.
62. Ghosh S, Gregory D, Smith A, Kobzik L, (2011) MARCO Regulates Early Inflammatory Responses against Influenza: A Useful Macrophage Function with Adverse Outcome. Am J Respir Cell Mol Biol 45: 1036-1044.
63. Dinarello CA, (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201: 1355-1359.
64. Vazquez-Torres A, Fantuzzi G, Edwards CK 3rd, Dinarello CA, Fang FC, (2001) Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages. Proc Natl Acad Sci U S A 98: 2561-2565.